VITTORIO, Serena
 Distribuzione geografica
Continente #
EU - Europa 1.599
NA - Nord America 1.173
AS - Asia 587
SA - Sud America 222
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 24
OC - Oceania 2
Totale 3.698
Nazione #
US - Stati Uniti d'America 1.143
RU - Federazione Russa 856
SG - Singapore 230
IT - Italia 200
BR - Brasile 186
IE - Irlanda 162
SE - Svezia 153
CN - Cina 137
HK - Hong Kong 63
DE - Germania 55
VN - Vietnam 54
FR - Francia 40
GB - Regno Unito 31
IN - India 25
FI - Finlandia 22
CA - Canada 16
CZ - Repubblica Ceca 16
PL - Polonia 12
ES - Italia 11
ID - Indonesia 11
AR - Argentina 10
BD - Bangladesh 10
ZA - Sudafrica 9
IQ - Iraq 7
NL - Olanda 7
EC - Ecuador 6
MX - Messico 6
UZ - Uzbekistan 6
VE - Venezuela 6
AT - Austria 5
BE - Belgio 5
IR - Iran 5
JP - Giappone 5
MA - Marocco 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
CL - Cile 4
GR - Grecia 4
JO - Giordania 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
LT - Lituania 3
LV - Lettonia 3
PH - Filippine 3
PT - Portogallo 3
TR - Turchia 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.608
Città #
Moscow 226
Ashburn 200
Dublin 162
Dallas 152
Singapore 121
Chandler 117
Nyköping 99
San Jose 93
Hong Kong 62
Beijing 46
Milan 39
Munich 38
Messina 37
The Dalles 37
Los Angeles 36
Council Bluffs 31
Princeton 23
Ho Chi Minh City 19
Lauterbourg 19
Medford 19
Des Moines 17
São Paulo 16
Turku 16
Brno 13
Santa Clara 13
Rome 11
Dearborn 10
New York 10
Pune 10
Redondo Beach 10
Buffalo 9
Hanoi 9
Hyderabad 9
Jakarta 9
Johannesburg 8
London 8
Nuremberg 7
Warsaw 7
Brasília 6
Brooklyn 6
Tashkent 6
Toronto 6
Tradate 6
Ann Arbor 5
Belo Horizonte 5
Denver 5
Frankfurt am Main 5
Jacksonville 5
Nanjing 5
Orem 5
Palermo 5
Stockholm 5
Tokyo 5
Wroclaw 5
Amman 4
Amsterdam 4
Atlanta 4
Cagliari 4
Catania 4
Curitiba 4
Dhaka 4
Dong Ket 4
Francofonte 4
Guangzhou 4
Lappeenranta 4
Madrid 4
Manchester 4
Poplar 4
Rio de Janeiro 4
San Francisco 4
San Mateo 4
Seattle 4
Shenyang 4
Shenzhen 4
Vienna 4
Athens 3
Baku 3
Boardman 3
Borghetto Santo Spirito 3
Brussels 3
Buenos Aires 3
Columbus 3
Florence 3
Fuzhou 3
Genoa 3
Goiânia 3
Guarujá 3
Lisbon 3
Monreale 3
Montreal 3
Naples 3
Newark 3
Nova Iguaçu 3
Olomouc 3
Riga 3
Roubaix 3
Serrastretta 3
São Gonçalo 3
Tianjin 3
Topeka 3
Totale 2.012
Nome #
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 227
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 218
Study and design of modulators of protein-protein interactions implicated in tumor and neurodegenerative diseases 216
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 204
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 203
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 193
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 183
Vitamin D: a steroid hormone with progesterone-like activity 173
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 172
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 163
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 163
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 151
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 149
Searching for alpha-syn inhibitors to fight Parkinson’s disease 145
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation 143
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 139
Discovery of a novel class of Tyrosinase inhibitors as antimelanogenic agents 137
Interaction of Aggregated Cationic Porphyrins with Human Serum Albumin 125
Exploring molecular contacts of muc1 at cin85 binding interface to address future drug design efforts 116
Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function 112
Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold 111
Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease 107
In silico identification of potential druggable binding sites on CIN85 SH3 domain 103
Synthesis, molecular docking and antibacterial activity of an oxadiazole-based lipoteichoic acid inhibitor and its metabolites 33
null 12
Totale 3.698
Categoria #
all - tutte 12.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 14 3 15 10 13 26 9 5 33 24 69
2022/2023470 42 72 21 24 23 41 11 24 191 0 17 4
2023/2024181 6 22 8 33 9 27 2 9 1 14 2 48
2024/2025680 19 16 4 40 40 18 31 143 141 40 86 102
2025/20261.911 113 132 141 124 155 395 225 266 238 71 30 21
2026/202765 29 36 0 0 0 0 0 0 0 0 0 0
Totale 3.698